Mila Pontremoli Salcedo, Natacha Phoolcharoen & Kathleen M. Schmeler. 2022. Comprehensive Gynecology. Comprehensive Gynecology
637
647.e2
.
Xia Zhang, Qing Zhang, Ke Zhang, Fang Wang, Xiaogai Qiao & Jinquan Cui. (2021) Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer. Cell Transplantation 30, pages 096368972098378.
Crossref
Alvaro Henrique Ingles Garces, Andreia Cristina de Melo, Eduardo Paulino, Angélica Nogueira-Rodrigues, Rachele Grazziotin, Márcio Lemberg Reisner, Mariane Sousa Fontes Dias, Gustavo Guitmann, Gustavo Iglesias & Carlos Gil Ferreira. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
491
549
.
Gloria Marquina, Aranzazu Manzano & Antonio Casado. (2018) Targeted Agents in Cervical Cancer: Beyond Bevacizumab. Current Oncology Reports 20:5.
Crossref
Mila M. B. P. Salcedo, Andrea P. S. Damin, Grasiela Agnes, Suzana A. Pessini, Patricia El Beitune, Claudio O. P. Alexandre, Kathleen M. Schmeler & Gustavo Py Gomes da Silveira. (2015) Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil. Archives of Gynecology and Obstetrics 292:6, pages 1273-1278.
Crossref
Ciro Comparetto & Franco Borruto. (2015) Molecular Technologies in Gynecologic Oncology. Journal of Cancer Research Updates 4:4.
Crossref
Alvaro Henrique Ingles Garces, Andreia Cristina de Melo, Angélica Nogueira-Rodrigues, Gustavo Guitmann, Gustavo Iglesias, Julia Alena Leite, Márcio Lemberg Reisner, Mariane Sousa Fontes Dias, Rachele Grazziotin & Carlos Gil Ferreira Moreira. 2015. International Manual of Oncology Practice. International Manual of Oncology Practice
435
486
.
Sonya J. Hwang & Kenneth R. Shroyer. (2012) Biomarkers of Cervical Dysplasia and Carcinoma. Journal of Oncology 2012, pages 1-9.
Crossref
Yang Li, Yao Yu, Yan Zhang, Yufei Zhou, Chao Li, Jianbing Zhu, Hanying Yuan & Hong Lu. (2011) MAFIP is a tumor suppressor in cervical cancer that inhibits activation of the nuclear factor‐kappa B pathway. Cancer Science 102:11, pages 2043-2050.
Crossref
Donna Dehn, Adriann Taylor, Timothy J. Fischer, Douglas P. Malinowski & Kenneth R. Shroyer. 2009. Inflammation and Cancer. Inflammation and Cancer
297
310
.
R.O. GreerJr.Jr., A. Meyers, S.M. Said & K.R. Shroyer. (2008) Is p16INK4a protein expression in oral ST lesions a reliable precancerous marker?. International Journal of Oral and Maxillofacial Surgery 37:9, pages 840-846.
Crossref
Donna Dehn, Kathleen C. Torkko & Kenneth R. Shroyer. (2007) Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111:1, pages 1-14.
Crossref
Kenneth R. Shroyer, Petra Homer, David Heinz & Meenakshi Singh. (2006) Validation of a novel immunocytochemical assay for topoisomerase II-α and minichromosome maintenance protein 2 expression in cervical cytology. Cancer 108:5, pages 324-330.
Crossref
X. LU & A. FEKI. (2006) Phenotypic features with p53 alterations related to human papillomavirus and prognostic evaluation in cervical cancer. International Journal of Gynecological Cancer 16:2, pages 708-717.
Crossref
Ji Shin Lee, Yoo Duk Choi, Jae Hyuk Lee, Jong Hee Nam, Chan Choi, Min Cheol Lee, Chang Soo Park, Hyung Seok Kim & Kyung Whan Min. (2006) Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. Journal of Surgical Oncology 93:3, pages 233-240.
Crossref
R Hasina, A L Pontier, M J Fekete, L E Martin, X M Qi, C Brigaudeau, R Pramanik, E I Cline, L J Coignet & M W Lingen. (2005) NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 25:4, pages 588-598.
Crossref
Ming-Ping Wu & Cheng-Yang Chou. (2005) Angiogenesis, Thrombospondin-1 and Cervical Carcinogenesis. Taiwanese Journal of Obstetrics and Gynecology 44:2, pages 128-138.
Crossref
James Goldie. 2005. Orbital Disease. Orbital Disease
95
106
.
Chih-Hsiang Chang, Tze-Ho Chen, Reuy-Chang Hsu, Pan-Hsin Chou, Jaw-Ji Yang & Guang-Yuh Hwang. (2005) The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan. Journal of Clinical Virology 32:1, pages 33-37.
Crossref
. 2004. Encyclopedic Dictionary of Genetics, Genomics and Proteomics. Encyclopedic Dictionary of Genetics, Genomics and Proteomics.
L.B. Jordan & H. Monaghan. (2004) Pathology of the Cervix: Recent Developments. Clinical Oncology 16:4, pages 248-254.
Crossref
Elke A Jarboe, L.Chesney Thompson, David Heinz, J.A McGregor & Kenneth R Shroyer. (2004) Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma. Human Pathology 35:4, pages 396-402.
Crossref
Peng-Hui Wang, Ywan Feng Li, Chi-Mou Juang, Yan-Ru Lee, Hsiang-Tai Chao, Heung-Tat Ng, Ying-Chieh Tsai & Chiou-Chung Yuan. (2002) Expression of Sialyltransferase Family Members in Cervix Squamous Cell Carcinoma Correlates with Lymph Node Metastasis. Gynecologic Oncology 86:1, pages 45-52.
Crossref
Shivaprakash Gangappa, Linda F. van Dyk, Travis J. Jewett, Samuel H. Speck & Herbert W. VirginIVIV. (2002) Identification of the In Vivo Role of a Viral bcl-2. The Journal of Experimental Medicine 195:7, pages 931-940.
Crossref
Elke A Jarboe, Kai-Li Liaw, L Chesney Thompson, David E Heinz, Paige L Baker, Jamie A McGregor, Terry Dunn, Jan E Woods & Kenneth R Shroyer. (2002) Analysis of telomerase as a diagnostic biomarker of cervical dysplasia and carcinoma. Oncogene 21:4, pages 664-673.
Crossref
Qi Ding, Lori Bramble, Vilma Yuzbasiyan-Gurkan, Thomas Bell & Katheryn Meek. (2002) DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia. Gene 283:1-2, pages 263-269.
Crossref